98
Intestinal parasites: clinical significance and diagnosis Tom van Gool, MD, PhD Department of Clinical Parasitology Academic Medical Center, Amsterdam, Netherlands

Intestinal parasites: clinical significance and diagnosis · Entamoeba dispar Entamoeba hartmanni Sarcocystis hominis Iodamoeba butschlii Chilomastix mesnili Helminths Schistosoma

  • Upload
    others

  • View
    12

  • Download
    0

Embed Size (px)

Citation preview

Intestinal parasites:

clinical significance and diagnosis

Tom van Gool, MD, PhD

Department of Clinical Parasitology

Academic Medical Center, Amsterdam, Netherlands

Persistent gastrointestinal illness after travel to

(sub) tropics: frequently observed.

intestinal parasites !

Protozoa

Helminths

E. histolytica Giardia lamblia Cryptosporidium Cyclospora Isospora D. fragilis

Ascaris Hookworm Taenia Strongyloides

Symptomatology due to intestinal parasites

most often non specific:

good laboratory diagnosis important !

Important intestinal protozoan pathogens

• Entamoeba histolytica

• Giardia lamblia

• Cyclospora caytanensis

• Cryptosporidium spp.

• Dientamoeba fragilis

• Microsporidia

Important human helminths….

● Schistosoma haematobium

● Schistosoma mansoni

● Schistosoma intercalatum

● Schistosoma japonicum

● Fasciola hepatica

● Clonorchis sinensis

● Opisthorchis spp.

● Ascaris lumbricoides

● Capillaria philippinensis

● Enterobius vermicularis ● Hookworms

● Strongyloides srecoralis

● Trichuris trichiura

● Diphyllobothrium latum

● Hymenolepis diminuta

● Hymenolepis nana

● Taenia spp.

Diagnostic stages of all intestinal parasites are

relative large and have a distinctive morphology.

Easy to recognize under a light microscope

for a well trained laboratory technician!

The “old way” of diagnosis

for intestinal parasites:

microscopy

S. mansoni

Ascaris

T. trichiura

C. cayetanensis

E. histolytica/

disparhookworm

G. lamblia

S. stercoralis

The value of microscopy: parasites observed by a well trained technician in a 10 min. search….

Three day collection kit, two

tubes filled with SAF- fixative

For high sensitivity of microscopy, especially

for protozoa, multiple stool samples should be

examined.

Newer diagnostic methods: PCR- (molecular) based

diagnosis for intestinal parasites ……

I

Technical advantages:

- high sensitivity

- high specificity

- one day stool sample sufficient (G)

- easy to combine with other

PCR’s of i.e. virology and

bacteriology…

- less (specialised) technicians

needed

- Good financial revenue for workload

DNA isol.

MP 96

PCR:

LC 480

PCR

1 day stool

sampling

possible !

Use of PCR - diagnosis in Dutch laboratories:

in routine clinical practice only a few intestinal

protozoans (3- 4) are examined

• Giardia lamblia

• Cryptosporidium spp.

• Entamoeba histolytica

(Dientamoeba fragilis)

No other protozoa and helminths !

Cost test in NL ~ 80 euro

Who was in contact

with the wormy world?

Helminth infections worldwide highly prevalent: travel

brings many in contact with the “wormy world”…

With known or possible travel to warm-climate countries

diagnosis of intestinal helminths should be included…!

they are indeed still imported in NL…!!

Schistosoma haematobium

Schistosoma mansoni

Schistosoma intercalatum

Schistosoma japonicum

Fasciola hepatica

Clonorchis sinensis

Opisthorchis spp.

Ascaris lumbricoides

Capillaria philippinensis

Enterobius vermicularis

Mijnworm

Strongyloides srecoralis

Trichuris trichiura

Diphyllobothrium latum

Hymenolepis diminuta

Hymenolepis nana

Taenia spp.

Diagnosed in AMC population

(in 2010-2018)

a new, efficient, method for diagnosis of intestinal parasites

The Dual - Feces - Test (DFT)

One day

collection kit

(two tubes) !

● Entamoeba histolytica

● Giardia lamblia

● Cryptosporidium

● Dientamoeba fragilis

● Blastocystis species*

● Microsporidia

● Cyclospora cayetanensis

● Isospora belli

● Entamoeba moshkovskii *

● Entamoeba chattoni*

● Entamoeba polecki*

Pathogenic protozoa Apathogenic protozoa

Endolimax nana

Entamoeba coli

Entamoeba dispar

Entamoeba hartmanni

Sarcocystis hominis

Iodamoeba butschlii

Chilomastix mesnili

Helminths

● Schistosoma haematobium

● Schistosoma mansoni

● Schistosoma intercalatum

● Schistosoma japonicum

● Fasciola hepatica

● Clonorchis sinensis

● Opisthorchis spp.

● Ascaris lumbricoides

● Capillaria philippinensis

● Enterobius vermicularis

● Mijnworm

● Strongyloides srecoralis

● Trichuris trichiura

● Diphyllobothrium latum

● Hymenolepis diminuta

● Hymenolepis nana

● Taenia spp.

Dual-Feces-Test (DFT)routine handling and targets

Diagnosis of 24 pathogens:

protozoa and helminths

(microscopy)

Improved sensitivity for

5 protozoal infections

(PCR)

PCR

PCR

PCR

++

++

Costs test in NL ~ 120 euro

+PCR

PCR

+

*pathogenicity debated

1,0

rare2,0

few

3,0

some

4,0

many

0,0

negative

microscopic load

20

25

30

35

40

45C

p P

CR

valu

e

Giardia+ PCR and – MICR:

- persisting DNA after (un-) successful treatment (?)

- lower sensitivity microscopy versus PCR

- contamination from surrounding (?)

Consultation with clinician important!

Initial withhold of treatment !

+ Micr. and + PCR: active

Giardia infection: in general

indication for therapy!

negative

Microscopic

threshold

Giardia in DFT: combined use Microscopy and PCR…

Amoebiasis

due to Entamoeba histolytica

an “old” but still most important - dangerous- cause

of intestinal and liver disease……

In older times (< 1990..) worldwide, specific round

cysts with microscopy, were all “Entamoeba histolytica”.

Majority is

Entamoeba dispar:

a non-pathogen!

Only minority is

Entamoeba histolytica:

a true pathogen!

New insights with

i.e. PCR methods:

Globally, 500 million people may harbour E.

histolytica and several tens of thousands die

each year as a consequence of fulminating

colitis or liver abscess (WHO 2018).

Growth and multiplication of E. histolytica in colon

Can be asymptomatic for many

years but….they are a true

ticking time-bomb!!

…at a time transformation into an invasive stage....

Severe colitis: can be lethal

Beware: in non- endemic countries….

DD E. histolytica infection and Crohn’s disease!

Numerous cases in world literature with presumed

“Crohn’s disease” while afterwards... amoebiasis

Before diagnosis of “Crohn’s disease”

always exclude E. histolytica infection!!

Diagnosis

● Microscopy: stool with blood: motile stages),

fast result ~15 min !

● PCR (only) highly sensitive, takes time

● Dual - Feces -Test: fast and high sensitivity

Spread of amebiasis from intestine to i.e. liver

Amoebic liver abcess: a potential deadly complication

Potential spread to thorax!

For diagnosis of amoebic abscess in the liver

serology is important !

Agglutination test (Fumouze)

• Fast and easy (15 min.)

• High sensitivity (93%) and specificity (99%)

• Incidentally false negative early in infection

+

CAP- test

Counter-immuno-electrophoresis

•Pos control

•Neg control

•Pat A undiluted

•Pat A 1:2 diluted

Serum of patientE. histolytica antigen

Test becomes negative after succesfull treatment!!

Serum case

with abces

Treatment

● Drainage of an amoebic

liver abcess

● Only with large abcess:

risk of bacterial contamination!

Treatment

● tissue phase: metronidazol (750 mg tid x 7-10d)

● luminal agents : clioquinol (3dd 250mgx 10d)

diloxanide furoate (3dd 500 mg 10d)

paromomycin (30 mg/kg x 7d)

Always treat with a luminal agent after

treatment of the tissue phase!

II Giardia lamblia

an important cause of prolonged diarrhoea in

both tropical and western countries

Giardia intestinalis

● worldwide prevalence

● faeco-oral transmission

● zoonosis

● highly prevalent among children

● located in small intestine

Symtomatology Giardia infection

• Asymptomatic carrier state: commonly occuring (80% infected)

important source of infection

• Acute diarrhoea: often self limiting (2- 4 weeks), weight loss,

abdominal cramps, nausea, flatulence,

steatorrhoea (in 50% of cases).

Chronic diarhoea: persistence of diarrhoea, weight

loss, impairment of growth and developement

especially in children in developing countries

Post infectious IBSPost infectious IBSPost infectious IBSPost infectious IBS

Diagnosis giardiasis

● Microscopy has limitations:

examination of one sample sensitivity (only) 70%.

● Need for examinations of multiple (3) samples with

microscopy for reliable result.

● Alternative: PCR or Dual-Feces-Test: one sample

examination is enough!

Para

sit

es in

faeces

Detection level microscopy

days

Current therapy

metronidazole: 500mg 3dd, 7 days

main alternatives:

tinidazol: 2 gram / day once (USA no.1) !!

albendazol: > 1 year: 400 mg. 1dd, 5 dgn

A frequent, under recognised, problem:

Regular treatment not effective to eradicate Giardia infection: nitroimidazole - resistant Giardiasis (Refractory Giardiasis , RG).

E.R. Carter, *, L.E. Nabarro 1, L. Hedley 2, P.L. Chiodini

The Hospital for Tropical Diseases, UK, Pharmacy, University College London

Hospitals NHS Foundation Trust, London, UK

How to deal with a patient with persistent Giardia

infection after standard treatment?

• Councelling for possible re-infections from environment :

partners (MSM), children, pets, and water sources.

• Examination for IgA deficiency, HIV, coeliac disease

When negative: possible true therapy resistance of Giardia

isolates. Difficult to examine in routine clinical practice !

start “pragmatic approach guided by experience” for

other treatment regimen (i.e. Carter 2017)

When negative: possible true nitroimidazle resistant Giardia

isolates. Not possible to examine in clinical practice

Suggested treatment regimens in RG:

1: tinidazol (1d, 2 gr) , albendazol (400 mg 2dd, 5d), tinidazol (1d, 2gr)“

2: mepacrine (100mg 3dd, 3-7d)

3: aldendazol (2dd 400mg, 14 d….(?))

Carter et al 2017++

also with microscopy!!

III Cyclospora cayetanensis

the “overlooked” parasite….

1986 Soave. Patients in Haiti and Mexico with

diarrhea. Structures 8 -10 µm, defined

wall, granular material inside: coccidian

body/fungal spore. “Big Crypto”.

Intestinal coccidian from distinct

protozoan genus

Humans only natural host.

Cyclospora cayetanensis

Intracellular location

small intestine

Diagnosis: relative easy with microscopy!

● 8-10 um with several globlets inside.

● when properly trained technicians “cannot miss it”!!

The importance of microscopy… also in NL!

Additional routine microscopy (10 min search) :

result: many cysts of Cyclospora

A group of persons with severe symptomatology i.e. severe

abdominal pain and loss of weight (8 kg in two weeks)

Standard: PCR for E. histolytica, Giardia and Cryptosporidium:

Result (2x): “No parasites” found.

All patients persisted, for two weeks, to be most ill !!!

Transmission: contaminated food (i.e.produce), water..

Prevalence:

many countries

- Latin America

●Guatamala

● Peru

● Mexico

- India

- SE Asia

- Also USA….

USA 2018: multiple outbreaks > 2000 cases (no int. travel)

Contaminated raspberries from Guatamala

Symptomatology associated with

Cyclospora infection

• patients often feel very ill!

• predominant symptom: watery diarrhea often in relapsing, cyclical pattern

• important associated symptoms:• heartburn-like symptoms, abdominal cramps

• fatigue

• anorexia, weight loss (up to 10 kg!) and vomiting

• infection may last for weeks (but is self-limiting)

Effective treatment available!!

In case of severe complaints:

Co-trimoxazole (trimethoprim - sulfamethoxazole

(160/800 mg) 2x dd for 7-10 days

Fast effect after start of treatment!

Intestinal protozoa observed with Triple Feces Test

(TFT) in routine practice (n: 462 patients) AMC

Giardia intestinalis 24 (5,2) Entamoeba histolytica/dispar 18 (3,9)

Dientamoeba fragilis 45 (9,7)

Blastocystis 124 (26,8)

Entamoeba coli 65 (14,0)Entamoeba hartmanni 23 (5,0)Endolimax nana 47 (10,2)Chilomastix mesnili 10 (2,2)Iodamoeba butschlii 12 (2,6)

Combined: positive in

about 30% of patients!!

Dientamoeba fragilis

a parasite of importance for childrenand (some) adults!

Clinical significance

Studies form USA and Canada 1977: symptomatic disease

in part (15 – 25%) of infected cases (75-85% no symptoms!)

Dientamoeba fragilis

Important to consider in children with persistent

intestinal complaints !

NTVG 2004

▪ 43 children with abdominal complaints and no other cause▪ treatment clioquinol or metronidazol (27C , 6 M/T)

▪ In 33 / 43 children after therapy eradication of parasites.In 27 out of 33 (82%) symptoms were considerably less or were completely disappeared.

▪ From 10 children without clearance of parasites after treatment, in 2 (20%) complaints were less or disappeared

Effects on symptomatology in children with DF after parasitological effective treatment (paromomycin)

:

Vandenberg et al.

Many other reports, worldwide, which suggest pathogenicity of D. fragilis…..

Simon et al. (1967)Spencer et al. (1979) Keystone et al. (1983)Dardick (1983)Millet et al. (1983)Oxner et al. (1987)Preiss et al. (1991) Butler (1996)Cuffari et al. (1998) Girginkardesler et al. (2003)Bosman et al. (2004) Vandenberg et al. (2006, 2007).Kurt et al. (2008)Stark et al. (2010)van Hellemond et al. (2012)

Longstanding worldwide evidence /observations that D. fragilis infections can elicit symptomatology in humans.

Pathogenesis is unknown

As with Giardia, there are also many asymptomatic carriers with DF !!

In The Netherlands….

After introduction of PCR for diagnosis of D. fragilis

no difference in prevalence in between symptomatic and asymptomatic individulas…

“D. fragilis is not (never) a cause of disease”

Diagnosis is also no longer indicated

End

But only in this country (NL), after

introduction of PCR for diagnosis,

D. fragilis is declared to be an

apathogen…!!

Fifty years English literature:

“ D. fragilis can, in a selected group of persons,

be a cause of symptomatology…”

?

Clinical practice after microscopic positive result: treatment for

D. fragilis offered to patients were no other causes for

complaints are found. In these cases often good response!

In practice: with PCR too many positives to treat all!

Loss of old selection criterion for indication of treatment,

and….observations of good effect of treatment

PCR diagnosis for Dientamoeba fragilis : a pitfall for interpretation of pathogenicity and4. clinical care !!

Additional no.

positives:

often low

DNA loads!

Patients with

symptomatology

due to D.fragilis

= small group

of total

No. positves with microscopy: No. positives with PCR: strong increase

@amc.uva.nl

Persistent DNA from D.fragilis present in bowl

after usage by patient with D. fragilis infection….

Current treatment options for Dientamoeba fragilis

Eff. ≈ 80-85%

Eff. ≈ 85-90%

Eff. ≈ 60-70%

▪ Use of clioquinol is safe in dosage of 3 dd 250 mg (adults) and 10-15 mg/kg/day divided in three doses (children), for 7-10 days.

▪ Neurotoxicity (SMON) described in Japan, especially after usage of high dosages in short period of time, or prolonged usage (months-years) . Side effects possible related to deficiency of Vit B12 in post war Japan.

▪ Outside Japan complications only seldom observed: only some cases described in over 500 million doses provided (!) , before side effects inJapan were noticed.

▪ No evidence of accumulation in the body after treatment in recent studies*:

▪ Clioquinol not detectable in plasma 3 days after 7-14 days of treatment with a dosage of 750 mg/day.

▪ Intracellular concentrations of clioquinol in Peripheral Blood Mononuclear cells very low after treatment with 800 mg/day for 8 days. Clinical no side effects < 2400 mg /day for 8 days.

*(potential use as anticancer agent: studies in 2003, 2007, 2012)

Clioquinol usage in The Netherlands:

with restricted use, it is safe.

(also in common use in Amsterdam UMC)

Practical aspects use of clioquinol

• Can be obtained from every pharmacy in NL

• Suspension 100 mg/ml according to FNA

• Preferable produced by “ De Magistrale Bereider” (preparation of a proper suspension is difficult)

• Do shake bottle thoroughly in advance: most important, otherwise “only water” will be used

• Important to calculate appropriate volume and instruct mother with handling of syringe

• Costs: relative cheap: 43 euro per bottle (= 100 ml of 100 mg/ml, )

• Dosage: 15 mg/kg/day (max 750 mg), divided over 3 doses, for 10 days.

Blastocystis spp. infection

an intriguing “new” field of interest !

Intestinal protozoan parasites observed in

routine clinical practice

• Entamoeba histolytica

• Giardia lamblia

• Dientamoeba fragilis

• Cryptosporidium spp.

• Isospora belli

• Cyclospora cayetanensis

• Microsporidia spp

Blastocystis hominis

• Entamoeba dispar

• Entamoeba coli

• Entamoeba hartmannii

• Iodamoeba butschlii

• Endolimax nana

• Chilomastix mesnili

pathogens

non- pathogens

Most common protozoan parasite (25%) !

Blastocystis spp:

many answers to be answered…!

• Taxonomic status …

• Mode of transmission….

• Clinical significance….

• Best diagnostic procedure….

• Effective therapy…..

But…..

• there were many more “subgroups” of Blastocystis!

• also common in animals!

• terminology was confusing: clusters, clades…

• now at least 14 species identified of which 4 species commonly are observed in humans

Formerly assumed in humans onlyone species: “Blastocystis hominis”

Prevalence and subtyping of Blastocystis spp. in samples routinely examined for intestinal parasites at Dept. Parasitology, AMC, Amsterdam (n = 442)

ST1; 5.2%

ST2; 5.2%

ST3; 9.7%

ST4; 2.7%

0,0%

5,0%

10,0%

15,0%

20,0%

25,0%

30,0%

pre

vale

nce

ST6ST7

Overall prevalence in population: 24%

Microscopy only

country

No Blasto infections

prevalence (%)

Netherlands

103

23

23

23

43

12

2

Denmark

197

nd

37

33

78

31

18

Turkey

87

nd

8

12

66

1

0%

20%

40%

60%

80%

100% Other ST

ST4

ST3

ST2

ST1

Different species in other studies using PCR on faeces

Belgium

108

27

12

49

13

32

1 4

12

41

6

28

Australia

91

19

Treatment options infection with Blastocystis spp.

it seems rather staightforward……

Review: Current therapy of Blastocystis spp. (Stensvold, JCG 2010)

80-90% eradication

95% eradication

86% eradication

77% eradication

However….treatment failure not uncommon:

diagnostic problems, resistance, other subtypes?

20 - 40%

effective?

40- 60%

effective?

???

Review: Current therapy of Blastocystis spp. (Stensvold, JCG 2010)

Coyle et al (CID 2012):

“Metronidazole is considered first line

treatment, but the success of eradicating

Blastocystis with this drug has been reported

to be anywhere from 0% to 100%”

Different Blastocystis species:Different fenotype on agar plates !

ST1: slimy colonies of variable size

ST4: smaller, separate, colonies !

End

Microsporidia

from an incidental to highly prevalent human pathogens….

“Small parasite, belongs to the microsporidia but

an unknown species: Enterocytozoon bieneusi

1985: a strange microorganism observed in a

patient with AIDS…

Microsporidia: old group of protozoan parasites, well known from diseases in animals.

Specific spore stages and invasion mechanism

Schottelius MI 2000

E.i.

Diagnosis

Microscopy on stool:

fast and easy

Molecular diagnosis (PCR): detection, species differentiation

Electron microscopy

i.e. small intestinal

biopsies

• chronic diarrhea

• cholangiopathy

• rhinosinusitis

Treatment difficult: fumagilin

Another strange parasite observed in AIDS in

epithelial cells of small intestine….

Encephalitozoon spp.!!

Spores of Encephalitozoon in urine in AIDS(Uvitex 2B)

Pathology due to Encephalitozoon infections in

AIDS: involvement of multiple organs

● encephalitis

● diarrhea

● hepatitis

● nephritis

● keratoconjunctivitis

Treatment of Encephalitozoon species

• Albendazole 400 mg twice a day for 4 weeks

– Rapid disappearance of spores from body fluids

– Prolonged treatment necessary to prevent

relapses

Microsporidiosis in immunosuppression other than AIDS

● Solid organ tranplantation (kidney, heart- long and liver)

● Bone marrow transplant recipiënts.

E. bienusi: prolonged diarrhea

Encephalitozoon spp.: multipe organ involvement

Antibodies to microsporidia frequently present in general Dutch and French population (7%)!

How do people come in contact with microsporidia?

Humans: E. bieneusi, E. intestinalis, E. hellem, E. cuniculi, Vittaforma corneae,, Nosema ocularum, Brachiola spp., Trachipleisthophora spp., Pleistophora spp and Microsporidum spp.

Animals: Enterocytozoon bieneusi i.e.: cats, chickens, dogs, goats, pigs, cattle, rats+++ Encephalitozoon intestinalis i.e.: donkeys, dogs, pigs, cows, goats, gorillas

Encephalitozoon cuniculi: i.e.: rabbits, rodents, foxes, goats, horses, birdsEncephalitozoon hellem i.e.: birds

Water: E. bieneusi, E. intestinalis,, Nosema, Pleistophora spp, Vittaforma cornea+

Food: Pleistophora spp.+/-

Insects: Brachiola algera, Nosema cornea+/-

Microsporidia are (indeed) close by……studies among Dutch pigeons

Sequence confirmed human microsporidia species in

36/331 (11%) pigeon feces samples !

Blatocystis infection: most common intestinal

protozoan in humans

Parasite Diagnostic yield (%)

Giardia intestinalis 24 (5,2) Entamoeba histolytica/dispar 18 (3,9)Dientamoeba fragilis 45 (9,7)

Blastocystis spp. 124 (26,8)

Entamoeba coli 65 (14,0)Entamoeba hartmanni 23 (5,0)Endolimax nana 47 (10,2)Chilomastix mesnili 10 (2,2)Iodamoeba butschlii 12 (2,6)

(no. examined 462 patients)

Most common protozoan parasite !

Culture of Blastocystis spp. in liquid media

Growth with intestinal bacteria:

difficult to estimate effectiveness of antibiotics!

. . . .. . . .

… . . . .

. . …

Axenic cultures (without bacteria) of

Blastocystis spp. needed for reliabe drug testing

Originally described by Tan, Exp. Par. 2000IMDM- HS, Iscove’s Modified Dulbecco’s Medium with 10% horse serum

► Culture of Blastocystis spp on agarplates

Disc diffusion testing of antibiotics with Blastocystis spp.

Subtype 1 with Ciprofloxacin en Furazolidone

Growth control:growth

CiprofloxacinGrowth: resistant

Furozolidone:Inhibition: sensitive

IV Strongyloides stercoralis

The “endless persisting” worm commonly

encountered in visitors returning from the tropics…

Continious replication in

intestine, migration to lungs,

swallowing, to intestine…

replication….and so on…

Birma railroad:

a monstrous project

of the Japanese in WOII…

In 47 out of 145 (33%) ex-prisoners of war

Strongyloides persisted for 45 year after

leaving the tropics!

Because of internal autoinfection potentially

life-long persistence once infected!

Prevalence

● Present in most tropical and subtropical countries

● Especially also South America (Surinam!) and

South East Asia (Indonesia).

● Also in rural areas Spain, Italia, Poland, Romania

Occasionally in Turkey

Symptomatology (immunocompetent host)

Acute phase: itching on spot of penetration,

moderate to severe diarrhea

Chronic phase: larva currensupper abdominal pain

malabsorption, diarrhea

eosinophilia

In general not too severe

The major complication of infection with

Strongyloides stercoralis infection

hyperinfection syndrome

Immunosuppression results in massive

proliferation of Strongyloides stercoralis!

Without prompt treatment: lethal condition!

Involvement of intestine, lungs and other organs….

IntestineLungs and

sputum

Patients at risk for hyperinfection syndrome:

- administration of corticosteroids (even 6-17 days courses)

- hematopoietic stem cell transplantation

- organ transplantation

- cytotoxic drugs

- Human T-lymphotropic virus type I (HTLV-I) infection

Prevention of hyperinfection syndrome

Anyone at risk: serodiagnosis with specific IgG

In case of a positive serological result: treatment with

ivermetine 0,2 mg/kg body weight daily, 2 days

Serodiagnosis of Strongyloides infection: most effective!!

ELISA: high sensitivity and specificity !

New test in routine use: Dual-Feces-Test (DFT)

1 day collecting set

Unfixed

Stool (A)

SAF-fixed

stool (B)

PCR (5 targets)

culture (yeasts)

Microscopy (25 targets)

Confirmation and

determination of protozoa

+

Op empirisch gronden werken met geneesmiddelen en

combinaties daarvan die in vivo bewezen effectiviteit hebben

tegen Giardia.

Meest gebruikt:

•Metronidazol

•Tinidazol

•Albendazol

•Paromomycine

•Nitazoxanide

•Meparicine

Combinaties: oa tinidazol met albendazol

Beleid behandeling

refractaire giardiasis

1: 1d tinidazol , 5d albendazol, 1d tinidazol“ We have chosen this regimen on the basis of the small trial performed by Cacopardo et al. which demonstrated the

superior efficacy of nitroimidazole–albendazole combination therapy over albendazole alone. Furthermore, in our

own experience, 60% of patients with refractory disease are cured with this combination”.

2: 3dd 100mg 3-5 (7) d Mepacrine

3: Aldendazol 2dd 400mg 14 d….(?)

-> Controle diagnostiek direct (tot 1 week) na einde

behandeling!

Carter et al 2017